Allen Institute extends cell line contract

By The Science Advisory Board staff writers

February 3, 2020 -- The Allen Institute for Cell Science announced on February 3 that it has extended its contract with the Coriell Institute for Medical Research for the storage and distribution of its Allen Cell Collection. Since its launch in 2016, the collection has grown from five cell lines to more than 40 lines today. The new agreement between the institutes will extend for an additional three years.

The collection is composed of gene-edited human induced pluripotent stem cell lines developed using CRISPR/Cas9 technology. The collection is ideal for live cell imaging to capture organelle dynamics and function in normal and disease models. Across the cell lines, 33 unique cellular structures have been tagged. With dual- and triple-edited cell lines, several key structures can be highlighted within the same cell.

With this extension, the Allen Institute will make the collection available to academic researchers and commercial entities.

The Coriell Institute for Medical Research will hold the cell lines in their biobanks. They will provide services in pipeline development with an emphasis on quality control and assessing the genomic, structural, and pluripotency integrity of cells.

Berkeley Lights launches Culture Station for faster cell processing
Berkeley Lights has announced the launch of Culture Station, a modular cell culture instrument that increases workflow capacity of optofluidic platforms,...

Copyright © 2020 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Conferences
2020 ACCP Annual Meeting
September 20-22
Bethesda, Maryland United States
Bioprocess International West
September 21-24
Eastern Standard Time Zone (EST) United States
BioProcess International
September 21-24
Eastern Standard Time Zone (EST), Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter